Life Sciences Times

Ventus Therapeutics Announces Collaboration with Genentech to Develop Small-Molecule Medicines Using ReSOLVE Platform

FDA Clears Access Vascular HydroMid and HydroPICC Catheters for Anti-Thrombogenic Use

MindWalk Names R. Scott Areglado as Chief Financial Officer to Drive Financial Strategy and Global Growth

Hologic to Be Acquired by Blackstone and TPG in $18.3 Billion Deal

Boston Scientific to Acquire Nalu Medical in $600 Million Deal to Expand Chronic Pain Solutions

Savara Announces Chief Medical Officer Transition

IMFINZI Regimen Reduces Risk of Disease Recurrence or Death by 32% in High-Risk Non-Muscle-Invasive Bladder Cancer in Phase III POTOMAC Trial

Pimicotinib Shows Deep and Durable Tumor Responses, Sustained Pain Relief, and Functional Improvement in TGCT Patients

Parabilis Medicines Unveils Groundbreaking Clinical Data Showing First-Ever Drugging of Key Cancer Driver with FOG-001

Diorasis Therapeutics Appoints Dr. Dimitri Azar to Board of Directors